Flemington, NJ, United States of America

Kalian Peters


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kalian Peters: Innovator in Pharmaceutical Ophthalmic Compositions

Introduction

Kalian Peters is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of pharmaceutical ophthalmic compositions. His innovative work focuses on developing effective treatments for eye conditions.

Latest Patents

Kalian Peters holds 1 patent for his invention titled "Pharmaceutical ophthalmic compositions." This patent describes compositions that consist of a therapeutically effective quantity of an anti-bacterial agent, such as moxifloxacin, and an anti-inflammatory agent, such as prednisolone. The compositions also include a combination of at least two solubilizing and suspending agents, one of which is a non-ionic polyoxyethylene-polyoxypropylene block copolymer, along with a suitable carrier. The patent outlines methods for fabricating these compositions and their applications in treating eye conditions.

Career Highlights

Throughout his career, Kalian Peters has worked with various organizations, including Novel Drug Solutions LLC and Eye Care Northwest, PA. His experience in these companies has allowed him to refine his expertise in pharmaceutical formulations and ophthalmic treatments.

Collaborations

Kalian has collaborated with professionals such as Jeffrey T. Liegner and John Scott Karolchyk. These partnerships have contributed to the advancement of his research and development efforts in the pharmaceutical field.

Conclusion

Kalian Peters is a dedicated inventor whose work in pharmaceutical ophthalmic compositions has the potential to improve eye care treatments. His innovative approach and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…